Tabel Pencarian Jumlah Artikel dengan Judul Sejenis

Results
No Keywords >10 tahun 10 tahun 5 tahun
terakhir terakhir
1. Drug related problems 38.437 17.306 9433
2. DM type 2 drugs 895 590 332
3. Drug related problems of DM type 2 drugs 12 8 5
4. Drug related problems of Diabetes mellitus type 2 drugs 104 60 32

Tabel Pencarian Jumlah Artikel Review dengan Judul Sejenis Berdasarkan Gol. Obat DM Type 2

Results
No Keywords 10 tahun 5 tahun
>10 tahun
terakhir terakhir
1 Drug related problems 9466 3870 1928
2 DM type 2 drugs 194 134 79
3 Drug related problems of sulfonilurea 17 8 3
4 Drug related problems of Alpha glucosidase inhibitors (AGIs) 11 7 4
5 Drug related problems of tiazolindindion 9466 3870 1928
6 Drug related problems of biguanid 27 14 6
7 Drug related problems of glinid/ meglitinid 0 0 0
8 Drug related problems of DPP 4 inhibitors 12 8 5
9 Drug related problems of GLP 1 agonist 10 8 6
10 Drug related problems of SGLT2 inhibitors 0 7 3

Gambar Hasil Pencarian Berdasarkan Golongan Obat DM type 2

1. DRPs
2. DM type 2 drugs
3. Drug related problems of sulfonylurea
4. Drug related problems of Alpha glucosidase inhibitors (AGIs)
5. Drug related problems of tiazolindindion
6. Drug related problems of biguanid
7. Drug related problems of glinid/ meglitinid
8. Drug related problems of DPP 4 inhibitors
9. Drug related problems of GLP 1 agonist
10. Drug related problems of SGLT2 inhibitors
Tabel Pencarian Jumlah Artikel Review dengan Judul Sejenis Berdasarkan Obat- obat dari Gol. Obat DM
Type 2

Golongan Dan Nama Obat >10 tahun 10 tahun terakhir 5 tahun terakhir
Sulfonylurea drugs
Glibenclamide 1 0 0
Glimepiride 0 0 0
Gliklazid 0 0 0
Gliquidon 0 0 0
Alpha glucosidase inhibitors (AGIs)
Miglitol 0 0 0
Acarbose 3 0 0
Tiazolindindion
Pioglitazone 8 2 2
Rosiglitazone 7 1 0
Biguanid
Metformin 34 20 5
Fenformin 0 0 0
Buformin 0 0 0
Glinid/ meglitinid
Repaglinid 4 0 0
Nateglinide 1 0 0
DPP 4 inhibitors
Sitagliptine 2 0 0
Linagliptine 1 1 0
Vidagliptine 2 0 0
SGLT2 inhibitors
Dapagliflozin 0 3 1
Empagliflozin 0 1 0
Canagliflozin 0 2 0
GLP 1 agonist
Exenatide 2 0 0
Liraglutide 3 2 0